35.19 USD
+0.11 (+0.31%)
35.19 USD
0 (0%)
IBEX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 86 industry peers in the IT Services industry. Both the health and profitability get an excellent rating, making IBEX a very profitable company, without any liquidiy or solvency issues. IBEX is evaluated to be cheap and growing strongly. This does not happen too often! These ratings would make IBEX suitable for value and growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year IBEX was profitable.
In the past year IBEX had a positive cash flow from operations.
Each year in the past 5 years IBEX has been profitable.
In the past 5 years IBEX always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 13.49%, IBEX belongs to the best of the industry, outperforming 92.94% of the companies in the same industry.
IBEX's Return On Equity of 27.45% is amongst the best of the industry. IBEX outperforms 89.41% of its industry peers.
IBEX has a better Return On Invested Capital (20.43%) than 94.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.49% | ||
| ROE | 27.45% | ||
| ROIC | 20.43% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IBEX has a Profit Margin of 6.60%. This is in the better half of the industry: IBEX outperforms 68.24% of its industry peers.
In the last couple of years the Profit Margin of IBEX has grown nicely.
With a decent Operating Margin value of 8.71%, IBEX is doing good in the industry, outperforming 65.88% of the companies in the same industry.
IBEX's Operating Margin has improved in the last couple of years.
IBEX has a Gross Margin of 30.91%. This is comparable to the rest of the industry: IBEX outperforms 43.53% of its industry peers.
IBEX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.71% | ||
| PM (TTM) | 6.6% | ||
| GM | 30.91% |
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBEX is creating value.
There is no outstanding debt for IBEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 5.10 indicates that IBEX is not in any danger for bankruptcy at the moment.
IBEX has a Altman-Z score of 5.10. This is in the better half of the industry: IBEX outperforms 75.29% of its industry peers.
IBEX has a debt to FCF ratio of 0.06. This is a very positive value and a sign of high solvency as it would only need 0.06 years to pay back of all of its debts.
The Debt to FCF ratio of IBEX (0.06) is better than 91.76% of its industry peers.
IBEX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
IBEX's Debt to Equity ratio of 0.01 is amongst the best of the industry. IBEX outperforms 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 5.1 |
ROIC/WACC2.28
WACC8.96%
2.3 Liquidity
IBEX has a Current Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.82, IBEX perfoms like the industry average, outperforming 56.47% of the companies in the same industry.
A Quick Ratio of 1.82 indicates that IBEX should not have too much problems paying its short term obligations.
IBEX's Quick ratio of 1.82 is in line compared to the rest of the industry. IBEX outperforms 56.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 41.96% over the past year.
IBEX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 41.04% yearly.
IBEX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.77%.
IBEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.62% yearly.
EPS 1Y (TTM)41.96%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%73.08%
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.55%
3.2 Future
IBEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.11% yearly.
IBEX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.28% yearly.
EPS Next Y16.57%
EPS Next 2Y12.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.8%
Revenue Next 2Y8.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 11.07, the valuation of IBEX can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of IBEX indicates a rather cheap valuation: IBEX is cheaper than 87.06% of the companies listed in the same industry.
IBEX is valuated cheaply when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.00 indicates a reasonable valuation of IBEX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IBEX indicates a rather cheap valuation: IBEX is cheaper than 88.24% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.59. IBEX is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.07 | ||
| Fwd PE | 10 |
4.2 Price Multiples
IBEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IBEX is cheaper than 87.06% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IBEX is valued a bit cheaper than the industry average as 63.53% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.37 | ||
| EV/EBITDA | 6.99 |
4.3 Compensation for Growth
IBEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IBEX may justify a higher PE ratio.
IBEX's earnings are expected to grow with 12.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.67
PEG (5Y)0.27
EPS Next 2Y12.11%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for IBEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
35.19
+0.11 (+0.31%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners94.9%
Inst Owner Change-3.89%
Ins Owners8.95%
Ins Owner Change-3.38%
Market Cap474.01M
Revenue(TTM)558.27M
Net Income(TTM)36.86M
Analysts45.71
Price Target39.27 (11.59%)
Short Float %1.24%
Short Ratio0.9
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.37%
Min EPS beat(2)10.89%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)13.65%
Min EPS beat(4)7.33%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)11.1%
EPS beat(12)10
Avg EPS beat(12)14.9%
EPS beat(16)11
Avg EPS beat(16)6.92%
Revenue beat(2)2
Avg Revenue beat(2)6.82%
Min Revenue beat(2)5.12%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.42%
Min Revenue beat(4)1.58%
Max Revenue beat(4)8.52%
Revenue beat(8)4
Avg Revenue beat(8)1.31%
Revenue beat(12)4
Avg Revenue beat(12)-0.58%
Revenue beat(16)6
Avg Revenue beat(16)-0.56%
PT rev (1m)0%
PT rev (3m)26.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.55%
EPS NY rev (1m)0%
EPS NY rev (3m)4.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.07 | ||
| Fwd PE | 10 | ||
| P/S | 0.85 | ||
| P/FCF | 17.37 | ||
| P/OCF | 10.38 | ||
| P/B | 3.53 | ||
| P/tB | 3.88 | ||
| EV/EBITDA | 6.99 |
EPS(TTM)3.18
EY9.04%
EPS(NY)3.52
Fwd EY10%
FCF(TTM)2.03
FCFY5.76%
OCF(TTM)3.39
OCFY9.63%
SpS41.45
BVpS9.97
TBVpS9.06
PEG (NY)0.67
PEG (5Y)0.27
Graham Number26.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.49% | ||
| ROE | 27.45% | ||
| ROCE | 25.17% | ||
| ROIC | 20.43% | ||
| ROICexc | 22.19% | ||
| ROICexgc | 23.83% | ||
| OM | 8.71% | ||
| PM (TTM) | 6.6% | ||
| GM | 30.91% | ||
| FCFM | 4.89% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 106.63% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 29.77 | ||
| Cash Conversion | 69.33% | ||
| Profit Quality | 74.04% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 5.1 |
F-Score8
WACC8.96%
ROIC/WACC2.28
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.96%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%73.08%
EPS Next Y16.57%
EPS Next 2Y12.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.55%
Revenue Next Year10.8%
Revenue Next 2Y8.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.91%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year66.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.92%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y27.21%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%
IBEX LTD / IBEX FAQ
Can you provide the ChartMill fundamental rating for IBEX LTD?
ChartMill assigns a fundamental rating of 7 / 10 to IBEX.
Can you provide the valuation status for IBEX LTD?
ChartMill assigns a valuation rating of 8 / 10 to IBEX LTD (IBEX). This can be considered as Undervalued.
What is the profitability of IBEX stock?
IBEX LTD (IBEX) has a profitability rating of 7 / 10.
Can you provide the financial health for IBEX stock?
The financial health rating of IBEX LTD (IBEX) is 7 / 10.
Can you provide the expected EPS growth for IBEX stock?
The Earnings per Share (EPS) of IBEX LTD (IBEX) is expected to grow by 16.57% in the next year.